Kestra Medical Technologies (KMTS) Income Statement

Kestra Medical Technologies reported revenue of $95.13M in fiscal 2026 (fiscal year ended Apr 30, 2026), up 59.0% from $59.81M a year earlier. Kestra Medical Technologies posted a net loss of $131.61M, compared with a net loss of $113.81M a year earlier. Gross margin was 51.4% and operating margin -141.6%. In the most recent quarter, Q1 fiscal 2027 (ended Jul 31, 2026), revenue was $30.97M, up 59.9% from the same quarter a year earlier.

Kestra Medical Technologies Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Kestra Medical Technologies, Ltd. income statement - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2021	FY 2019
Period ending	Apr 2026	Apr 2025	Apr 2024	Apr 2023	Apr 2021	Apr 2020
Revenue & Gross Profit
Revenue	95.13	59.82	27.81	7.63	0.00	0.00
Cost of Revenue	46.26	35.61	27.45	18.28	0.00	0.00
Gross Profit	48.86	24.21	0.36	-10.65	0.00	0.00
Operating Expenses
Research & Development	19.48	15.65	15.49	15.76	18.81	22.80
Selling, General & Administrative	164.12	114.94	69.94	54.01	13.90	6.52
Operating Expenses	183.60	130.59	85.43	69.77	32.71	29.32
Operating Income	-134.74	-106.38	-85.06	-80.42	-32.71	-29.32
Other Income/Expense
Interest Income	8.35	3.20	0.00	0.00	0.00	0.00
Interest Expense	7.55	7.73	6.23	5.63	-1.17	0.00
Other Income/Expense	2.62	-7.30	-2.80	-3.80	-1.21	0.00
Income
Income Before Tax	-131.32	-113.68	-94.10	-84.22	-33.91	-29.32
Income Tax Expense	0.29	0.14	0.02	0.02	0.19	0.15
Net Income	-131.61	-113.81	-94.12	-86.74	-34.10	-29.47
Net Income - Continuous Operations	-131.61	-113.81	-94.12	-84.24	-34.10	-29.47
Net Income - Discontinued Operations	-	-	-	-	-	-
EBITDA	-115.06	-97.98	-76.31	-80.42	-32.29	-28.84
EBIT	-123.77	-106.38	-87.87	-80.42	-32.71	-29.32
Depreciation & Amortization	8.71	7.97	11.56	4.86	0.42	0.48
Earnings Per Share
Basic EPS	-2.00	-5.00	-5.00	-820.00	-322.00	-1.00
Diluted EPS	-2.00	-5.00	-5.00	-820.00	-322.00	-1.00
Basic Shares Outstanding	54.18	49.53	19.89	0.11	0.11	49.53
Diluted Shares Outstanding	54.18	49.53	19.89	0.11	0.11	49.53

Source: Company financial statements from annual and quarterly filings. Data as of Jul 31, 2026. Data sources and methodology

Frequently Asked Questions About Kestra Medical Technologies Financial Statements

What was Kestra Medical Technologies's revenue in fiscal 2026?

Kestra Medical Technologies reported revenue of $95.13M in fiscal 2026 (fiscal year ended Apr 30, 2026). That was up 59.0% from $59.81M a year earlier.

Is Kestra Medical Technologies profitable?

No. Kestra Medical Technologies reported a net loss of $131.61M in fiscal 2026. In fiscal 2025 it lost $113.81M.

What is Kestra Medical Technologies's operating margin?

Kestra Medical Technologies's operating income was −$134.74M on revenue of $95.13M in fiscal 2026, an operating margin of -141.6%, compared with -177.8% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition